FdaApplication
NDA 219016
Identifiers
- fda_app_no: NDA219016
Properties
| Property | Value |
|---|---|
| applicant_name | JANSSEN PRODUCTS LP |
| application_type | NDA |
| approval_date | 2024-03-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EDURANT PED | RILPIVIRINE HYDROCHLORIDE | EQ 2.5MG BASE | TABLET, FOR SUSPENSION;ORAL |
1 product